Use of Nuclear Factor of Activated T Cell-Regulated Gene Expression for Monitoring Immunosuppression with Extended-Release Tacrolimus after Liver Transplantation—A Proof of Concept
Thus, tailored immunosuppression based on residual NFAT-RGE could prevent infections associated with over-immunosuppression early after liver transplantation.
Authors
- Peter Schemmer (ORCID: https://orcid.org/0000-0002-4192-6155)
- Eva Maria Matzhold (ORCID: https://orcid.org/0000-0002-4914-9880)
- Peter Schlenke (ORCID: https://orcid.org/0000-0002-3271-3836)
- Judith Kahn (ORCID: https://orcid.org/0000-0003-2341-6386)
Institutions
- Medical University of Graz (AT)
- Hirslanden Klinik Beau-Site (CH)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3390/pharmaceutics16101317
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00